27. Dezember 2017 | Naloxon
Opt-out versus opt-in: should take-home naloxone be required as safe clinical practice?
Opt-out versus opt-in: should take-home naloxone be required as safe clinical practice?
John Strang, Lisbon Addictions 2017, Second European Conference on Addictive Behaviours and Dependencies, Lissabon, 24.-26.10.2017
http://www.emcdda.europa.eu/…